Top results
biocon biologics investor presentation transforming healthcare transforming lives december 2019 1 safe harbour certain statements in this release concerning our future growth…
1 | p a g e raghvendra kumar [email protected] outperformer current price rs 404 target price rs 567 potential upside 40% time frame 12-15 months biocon (biocon)…
november 12 2019 to the manager bse limited department of corporate services phiroze jeejeebhoy towers dalal street mumbai- 400 001 scrip code -532523 dear sirmadam subject:…
biocon limited investor presentation november 2017 bse: 532523 │ nse: biocon │ reuters: bion.ns │ bloomberg: bios in │ www.biocon.com 2 safe harbor certain statements…
biocon human resource management company profile leading biotech firm of india and among top 20 in the world, founded in 1978 fully integrated model from pre-clinical…
submitted by girish chandra.p kiran mazumdar shaw chairman and managing director •postgraduate in malting and brewing from ballarat college melbourne university, australia.…
²)o) g«)«)1r: ²n)u]nr!u)1)n !o t1o¡hn))nr«u!1rni j))o:n!1o) tjoco² 8? ť a8plsplk cuÞ1a a8llul ka?al ul8al cpcuupa8l sp8auupa napa1a lacul1? ť Þ8clŦ 1l81panka8…
biocon limited q2 & h1 fy13 earnings conference call transcript october 31, 2012 participants from biocon group’s senior management team kiran mazumdar shaw: chairman…
indiaâs biotech queen-the economist and fortune indiaâs mother of invention- new york times all for this one moment - kiran mazumdar shaw kiran mazumdar shaw â the timeline…
8/2/2019 brand biocon 1/170brandbioconat the intersection of patient + therapyannual report 20118/2/2019 brand biocon 2/1708/2/2019 brand biocon 3/170diabetologyoncotherapeuticsnephrologycardiologycomprehensive…
8/8/2019 biocon ivmp 1/158/8/2019 biocon ivmp 2/15biocon is india's leadingbiocon is india's leadingbiotechnology enterprise.biotechnology enterprise.biocon is india's firstbiocon…
8/3/2019 biocon ar2011 1/164brandbioconat the intersection of patient + therapyannual report 20118/3/2019 biocon ar2011 2/1648/3/2019 biocon ar2011 3/164diabetologyoncotherapeuticsnephrologycardiologycomprehensive…
8/4/2019 biocon stm 1/158/4/2019 biocon stm 2/158/4/2019 biocon stm 3/158/4/2019 biocon stm 4/158/4/2019 biocon stm 5/158/4/2019 biocon stm 6/158/4/2019 biocon stm 7/158/4/2019…
8/9/2019 biocon presentation 1/28investor presentationseptember 20118/9/2019 biocon presentation 2/28certain statements in this release concerning our future growth prospects…
8/3/2019 biocon lmtd 1/36india, biotechnology and patentsindustry perspectivemadhav kulkarnibiocon limited, bangalore8/3/2019 biocon lmtd 2/362outline india and biotechnology…
8/7/2019 biocon final 1/21kiran mazumdar shawthe biocon story8/7/2019 biocon final 2/21biocon info.y company's slogan: driving innovation deliveringaffordabilityycompany's…
untitledthe global biopharmaceutical landscape has undergone tectonic change. complex challenges of drug development and evolving market dynamics have caused the industry
to scrip code - 532523 biocon limited 20th km hosur road electronics city bangalore 560 100. india t 91 80 2808 2808 f 91 80 2852 3423 cin : l24234ka1978plc003417 www.biocon.com
biocon iii system biocon iii synoptic data system capacity: 43800 litersday organic load capacity: 2256 kg bod5day overall dimensions: 1800x1600x1100 mm dry weight: 500kg…
january 29, 2018 icici securities ltd | retail equity research result update biologics, syngene maintain momentum… biocon reported flat yoy revenues at | 1058 crore…